Ulrika Harmenberg
Impact in
-
- Renal cell carcinoma treatment
- Prostate Cancer Treatment and Research
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
Papers in
-
- Renal cell carcinoma treatment 24
- Prostate Cancer Treatment and Research 4
- Oncology 13
- Pancreatic and Hepatic Oncology Research 4
- Colorectal Cancer Treatments and Studies 4
- Cancer Immunotherapy and Biomarkers 3
- Co-authors
- Börje Ljungberg (10 shared papers)Sven Lundstam (9 shared papers)Per Lindblad (7 shared papers)Andreas Thorstenson (5 shared papers)Britta Wahrén (10 shared papers)Saeed Dabestani (1 shared paper)Bernard J. Escudier (4 shared papers)Sten F. Nilsson (6 shared papers)
- Journals
- Acta Oncologica (5 papers)British Journal of Cancer (3 papers)Annals of Oncology (2 papers)Tumor Biology (2 papers)OncoImmunology (2 papers)
- Partner nations
- SwedenUnited KingdomUnited States
In The Last Decade
Ulrika Harmenberg
52 papers receiving 3.4k citations
Ulrika Harmenberg's Hit Papers
Peers
Comparison fields: 5 of 82
- Pulmonary and Respiratory Medicine 2.2k
- Oncology 616
- Cancer Research 116
- Immunology 143
- Radiology, Nuclear Medicine and Imaging 148
Countries citing papers authored by Ulrika Harmenberg
This map shows the geographic impact of Ulrika Harmenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulrika Harmenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulrika Harmenberg more than expected).
Fields of papers citing papers by Ulrika Harmenberg
This network shows the impact of papers produced by Ulrika Harmenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulrika Harmenberg. The network helps show where Ulrika Harmenberg may publish in the future.
Co-authors
The 25 scholars most cited alongside Ulrika Harmenberg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma Hit paper breakdown → | 2013 | 1585 |
| 2 | 2016 | 219 | |
| 3 | 2017 | 193 | |
| 4 | 2009 | 175 | |
| 5 | 2013 | 155 | |
| 6 | 2008 | 102 | |
| 7 | 2013 | 84 | |
| 8 | 2012 | 62 | |
| 9 | 2005 | 60 | |
| 10 | 2018 | 59 | |
| 11 | 2023 | 59 | |
| 12 | 1999 | 55 | |
| 13 | 2018 | 50 | |
| 14 | 1999 | 47 | |
| 15 | 1988 | 42 | |
| 16 | 2011 | 38 | |
| 17 | Tumor markers carbohydrate antigens CA 19-9 and CA-50 and carcinoembryonic antigen in pancreatic cancer and benign diseases of the pancreatobiliary tract. | 1988 | 37 |
| 18 | 1993 | 37 | |
| 19 | 2014 | 35 | |
| 20 | 1997 | 32 |
About Ulrika Harmenberg
Ulrika Harmenberg is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Immunology, Radiology, Nuclear Medicine and Imaging and Endocrinology, Diabetes and Metabolism, having authored 53 papers that have together received 3.5k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (24 papers), Pancreatic and Hepatic Oncology Research (4 papers), Prostate Cancer Treatment and Research (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Colorectal Cancer Treatments and Studies (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), T-cell and B-cell Immunology (3 papers) and Immunotherapy and Immune Responses (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (2.2k citations), Oncology (616 citations), Cancer Research (116 citations), Immunology (143 citations) and Radiology, Nuclear Medicine and Imaging (148 citations). Ulrika Harmenberg has collaborated with scholars based in Sweden, United Kingdom and United States. Frequent co-authors include Börje Ljungberg, Sven Lundstam, Per Lindblad, Andreas Thorstenson, Britta Wahrén, Saeed Dabestani, Bernard J. Escudier, Sten F. Nilsson, Per Sandström and Anders Ullén. Their work appears in journals such as Acta Oncologica, British Journal of Cancer, Annals of Oncology, Tumor Biology and OncoImmunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.